Effect of MG132, a proteasome inhibitor, on the expression of growth related oncogene protein-α in human umbilical vein endothelial cells
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Proteasome inhibitor MG‐132 enhances the expression of interleukin‐6 in human umbilical vein endothelial cells: Involvement of MAP/ERK kinaseImmunology & Cell Biology, 2002
- Production of growth related oncogene protein-α in human umbilical vein endothelial cells stimulated with soluble interleukin-6 receptor-α: role of signal transducers, janus kinase 2 and mitogen-activated kinase kinaseLife Sciences, 2002
- Expression, modulation and signalling of IL-17 receptor in fibroblast-like synoviocytes of patients with rheumatoid arthritisClinical and Experimental Immunology, 2002
- Growth Regulated Oncogene-α expression by murine squamous cell carcinoma promotes tumor growth, metastasis, leukocyte infiltration and angiogenesis by a host CXC Receptor-2 dependent mechanismOncogene, 2000
- Role of I Bα Ubiquitination in Signal-induced Activation of NF- B in VivoJournal of Biological Chemistry, 1996
- Thrombin induces production in human umbilical vein endothelial cellsThrombosis Research, 1995
- Properties of the Novel Proinflammatory Supergene "Intercrine" Cytokine FamilyAnnual Review of Immunology, 1991
- Recombinant expression, biochemical characterization and biological activities of the human MGSA/gro proteinBiochemistry, 1990
- Lipopolysaccharide-stimulated human monocytes secrete, apart from neutrophil-activating peptide 1/interleukin 8, a second neutrophil-activating protein. NH2-terminal amino acid sequence identity with melanoma growth stimulatory activity.Journal of Experimental Medicine, 1990
- Purification of melanoma growth stimulatory activityJournal of Cellular Physiology, 1986